FY2025 · period end Jun '25 · from the 10-K filed Aug 20, 2025
| Metric | FY25Jun '25 | FY24Jun '24 | FY23Jun '23 | FY22Jun '22 | FY21Jun '21 |
|---|---|---|---|---|---|
| Revenue | $1.11B | $1.07B | $1.00B | $0.96B | $0.86B |
| Gross Profit | $0.20B | $0.21B | $0.21B | $0.20B | $0.18B |
| Operating Income | $0.08B | $0.09B | $0.09B | $0.09B | $0.09B |
| Net Income | $0.06B | $0.06B | $0.06B | $0.06B | $0.06B |
| EPS (Diluted) | $5.03 | $4.95 | $4.98 | $5.33 | $5.17 |
| Metric | FY25Jun '25 | FY24Jun '24 | FY23Jun '23 | FY22Jun '22 | FY21Jun '21 |
|---|---|---|---|---|---|
| Total Assets | $0.60B | $0.52B | $0.43B | $0.45B | $0.40B |
| Total Liabilities | $0.24B | $0.19B | $0.13B | $0.17B | $0.16B |
| Stockholders' Equity | $0.36B | $0.32B | $0.29B | $0.28B | $0.24B |
| Cash & Equivalents | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Debt | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Metric | FY25Jun '25 | FY24Jun '24 | FY23Jun '23 | FY22Jun '22 | FY21Jun '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.03B | $0.10B | $0.12B | $0.02B | $0.10B |
| Capital Expenditures | $0.05B | $0.03B | $0.02B | $0.02B | $0.03B |
| Free Cash Flow | negative: -$0.02B | $0.07B | $0.10B | $0.00B | $0.08B |
| Metric | FY25Jun '25 | FY24Jun '24 | FY23Jun '23 | FY22Jun '22 | FY21Jun '21 |
|---|---|---|---|---|---|
| Gross Margin | 18.4% | 20.1% | 21.2% | 20.9% | 21.5% |
| Operating Margin | 0.1% | 8.0% | 0.1% | 0.1% | 0.1% |
| Net Margin | 0.1% | 5.6% | 0.1% | 0.1% | 0.1% |
| Return on Equity | 18.1% | 18.7% | 22.0% | 22.2% | 24.9% |
| Return on Assets | 10.6% | 11.7% | 13.1% | 13.8% | 14.8% |
| Debt / Equity | 0.04× | 0.02× | 0.02× | 0.03× | 0.04× |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001193125-26-306138 | Jul 15, 2026 | Jul 16, 2026 | Jul 16, 2026 20:15 UTC | EDGAR |
| 8-K | 0001193125-26-304782 | Jul 15, 2026 | Jul 15, 2026 | Jul 15, 2026 20:14 UTC | EDGAR |
| 8-K | 0001193125-26-191599 | Apr 29, 2026 | Apr 29, 2026 | Apr 29, 2026 20:13 UTC | EDGAR |
| 10-Q | 0001193125-26-191644 | Mar 26, 2026 | Apr 29, 2026 | Apr 29, 2026 20:16 UTC | EDGAR |
| 8-K | 0001193125-26-131798 | Mar 30, 2026 | Mar 30, 2026 | Mar 30, 2026 21:30 UTC | EDGAR |
| 8-K | 0001193125-26-029383 | Jan 29, 2026 | Jan 29, 2026 | Jan 29, 2026 21:16 UTC | EDGAR |
| 10-Q | 0001193125-26-029438 | Dec 25, 2025 | Jan 29, 2026 | Jan 29, 2026 21:27 UTC | EDGAR |
| 8-K | 0001193125-25-258566 | Oct 29, 2025 | Oct 30, 2025 | Oct 30, 2025 20:15 UTC | EDGAR |
Direct links to SEC EDGAR. JBSS has additional filings available on the SEC site.
6 numbers SANFILIPPO JOHN B & SON INC later changed — same XBRL tag, both filings linked.
Operating Income (Loss)·Q3 2017
Notable restatementwas$10.4M
Revised up in a 10-K.
Operating Income (Loss)·3 months to Jun 2017
Notable restatementwas$11.6M
Revised up in a 10-K.
Operating Income (Loss)·Q1 2016
Notable restatementwas$16.6M
Revised up in a 10-K.
Operating Income (Loss)·Q2 2016
Notable restatementwas$19.7M
Revised up in a 10-K.
Net Income (Loss) Attributable to Parent·Q3 2017
Notable restatementwas$10.4M
Revised up in a 10-K. Any P/E built on the original was 2.6% too high.
Net Income (Loss) Attributable to Parent·Q3 2017
Minor restatementwas$7.8M
Revised down in a 10-K. Any P/E built on the original was 1.9% too low.
JBSS is not the only one.
See every restatement we've found across the market — or get an alert the next time JBSS revises a number.
Restatements are detected by comparing every vintage of a fact across all of SANFILIPPO JOHN B & SON INC's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows JBSS's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling SANFILIPPO JOHN B & SON INC — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on JBSS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on JBSS and publish the result to your public profile.
Ask about SANFILIPPO JOHN B & SON INC
Continue in Workspace — cited answers on JBSS, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs